Related Experiment Video
Updated: May 10, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
[Lung cancer projections for Aragon (Spain)]
M Bernal1, D L B Souza, F J Gómez
1Departamento de Medicina Preventiva, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, España; Sección de Medicina Preventiva, Hospital Universitario Lozano Blesa, Zaragoza, España.
Introduction And Objective:
Lung cancer has a high incidence in Aragon (Spain). Current measures, such as stopping smoking, may lead to a change in lung cancer trends. The objective of the study is to track the trends during the period of 15 years from 2008 to 2022.
Participants And Methods:
The mortality from all causes and that specific to lung cancer in Aragon between 1998 and 2007 was analysed using the statistical program MIAMOD/PIAMOD to estimate incidence rates, prevalence, and mortality until 2022.
Results:
Projections between 2008 and 2022 in men: adjusted incidence rates per 100,000 will decline from 64.62 to 58.49. The mortality will decline from 57.41 to 51.95, and the prevalence of 94.13 cases per 100,000 inhabitants to 88.45. In women, the adjusted incidence rate will increase from 8.3 to 10.58, with a mortality of 7.21 to 9.18 and a prevalence from 14.78 to 18.75.
Conclusions:
These projections indicate that lung cancer incidence and mortality will remain a serious problem in the Aragon (Spain), and that a more intense primary prevention program is needed.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Other Pulmonary Disorders
Cancer Survival Analysis